CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 115 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,839,357 | +27.7% | 123,364 | -6.2% | 0.00% | 0.0% |
| Q2 2023 | $1,440,692 | +39.0% | 131,570 | +10.7% | 0.00% | 0.0% |
| Q1 2023 | $1,036,189 | +42.2% | 118,829 | +2.3% | 0.00% | 0.0% |
| Q4 2022 | $728,656 | +117.5% | 116,213 | +21.6% | 0.00% | – |
| Q3 2022 | $335,000 | +121.9% | 95,594 | +87.3% | 0.00% | – |
| Q2 2022 | $151,000 | -2.6% | 51,027 | +2.3% | 0.00% | – |
| Q1 2022 | $155,000 | -16.2% | 49,872 | -9.1% | 0.00% | – |
| Q4 2021 | $185,000 | +50.4% | 54,863 | +62.8% | 0.00% | – |
| Q3 2021 | $123,000 | -42.0% | 33,698 | -30.8% | 0.00% | – |
| Q2 2021 | $212,000 | +38.6% | 48,698 | +44.8% | 0.00% | – |
| Q1 2021 | $153,000 | +37.8% | 33,633 | +74.4% | 0.00% | – |
| Q4 2020 | $111,000 | -20.7% | 19,283 | -0.4% | 0.00% | – |
| Q3 2020 | $140,000 | +278.4% | 19,359 | +82.2% | 0.00% | – |
| Q2 2020 | $37,000 | -52.6% | 10,625 | -30.3% | 0.00% | – |
| Q3 2019 | $78,000 | -27.1% | 15,239 | +2.2% | 0.00% | – |
| Q2 2019 | $107,000 | -47.0% | 14,915 | -2.1% | 0.00% | – |
| Q1 2019 | $202,000 | +4.7% | 15,238 | -37.9% | 0.00% | -100.0% |
| Q4 2018 | $193,000 | -31.6% | 24,528 | -3.5% | 0.00% | 0.0% |
| Q3 2018 | $282,000 | +116.9% | 25,422 | +154.2% | 0.00% | – |
| Q1 2018 | $130,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,787,094 | $26,645,572 | 14.80% |
| Lynx1 Capital Management LP | 994,161 | $14,822,941 | 9.80% |
| Octagon Capital Advisors LP | 3,073,750 | $45,829,613 | 7.04% |
| Saturn V Capital Management LP | 1,124,459 | $16,765,684 | 7.02% |
| Altium Capital Management LP | 800,000 | $11,928,000 | 6.22% |
| Affinity Asset Advisors, LLC | 1,129,376 | $16,838,996 | 4.74% |
| ACUTA CAPITAL PARTNERS, LLC | 418,000 | $6,232,380 | 4.18% |
| Cormorant Asset Management, LP | 3,850,000 | $57,403,500 | 3.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 590,000 | $8,796,900 | 2.67% |
| MPM BioImpact LLC | 610,770 | $9,106,581 | 2.43% |